Dr. William Carson III, MD

• General Surgery

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Southern California Keck School Of Medicine

  Medical School, 1986

• Social Support and Socioeconomic Status Interact to Predict Epstein-BarrVirus Latency in Women Awaiting Diagnosis or Newly Diagnosed with Breast Cancer, 2011-10-17

• Fatigue and herpesvirus latency in women newly diagnosed with breast cancer, 2011-10-02

• Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function, 2019-03-25

• Defining the critical hurdles in cancer immunotherapy, 2011-12-14

• Giant breast tumors: Surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature, 2008-11-11

• A naonoporous cell-therapy device with controllable biodegradation for long-term drug release, 2012-12-07

• Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma, 2021-10-12

• Psychologic Intervention Improves Survival for Breast Cancer Patients A Randomized Clinical Trial, 2008-12-15

• Guided migration analyses at the single-clone level uncover cellular targets of interest in tumor-associated myeloid-derived suppressor cell populations, 2020-01-27

• Review of S100A9 Biology and its Role in Cancer, 2012-11-01

• Within-person changes in cancer-related distress predict breast cancer survivors' inflammation across treatment, 2020-09-09

• A phase I study of recombinant (r) Vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-a-2b in patients with CEA expressing carcinomas, 2016-08-31

• Delayed Emotional Recovery After Taxane-based Chemotherapy, 2008-08-01

• Expression of microRNAs and their target genes in melanomas originating from gynecologic sites, 2023-06-29

• Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery, 2007-02-09

• Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer, 2021-01-13

• An IL-15-based super agonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck, 2019-07-23

• Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer, 2023-05-18

• Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12, 2015-10-15

• Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants, 2010-06-08

• Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment, 2021-04-05

• Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammation, 2022-07-06

• Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma QUINN et al., 2018-11-06

• Alterations in Patient Plasma microRNA Expression Profiles Following Resection of Metastatic Melanoma, 2018-08-21

• Circulating myeloid derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer, 2017-07-07

• Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer, 2016-11-26

• A Phase II trial of Bevacizumab and High Dose Interferon Alpha-2B in Metastatic Melanoma, 2011-05-18

• Social support predicts inflammation, pain, and depressive symptoms: Longitudinal relationships among breast cancer survivors, 2014-01-05

• Reciprocal regulation of activating and inhibitory Fc? receptors by TLR7/8 activation: Implications for tumor immunotherapy, 2010-03-23

• Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment, 2020-05-18

• MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor, 2015-01-14

• Folate-Immunoglobulin G as an Anticancer Therapeutic Antibody, 2010-05-19

• A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab, 2008-12-03

• Immunotherapy of Head and Neck Cancer: Emerging Clinical Trials From a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting, 2016-12-01

• Pain, Depression, and Fatigue: Loneliness as a Longitudinal Risk Factor, 2013-08-19

• Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells, 2010-04-14

• Analysis of MLN4924 (Pevonedistat) as a Potential Therapeutic Agent in Malignant Melanoma, 2018-06-28

• The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity, 2010-06-25

• A phase 2 clinical trial of nivolumab and temozolomide for neuroendocrine neoplasms, 2023-02-16

• Emerging roles of and therapeutic strategies targeting BRD4 in cancer, 2019-02-04

• A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer, 2016-07-25

• Interleukin-21 activates natural killer cell activity against cetuximab-coated pancreatic tumor cells, 2015-11-04

• Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer, 2013-07-15

• NKp80 defines a critical step during human natural killer cell development, 2016-06-30

• Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature, 2019-03-25

• Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro, 2019-05-28

• A phase I/II trial of cetuximab in combination with interleukin-12 administered to patients with unresectable primary or recurrent head and neck squamous cell carcinoma, 2019-05-29

• Global MicroRNA Profiling for Diagnostic Appraisal of Melanocytic Spitz Tumors, 2016-07-04

• Cognitive Problems Among Breast Cancer Survivors: Loneliness Enhances Risk, 2014-04-11

• In situdeployment of engineered extracellular vesicles into the tumor niche via myeloid-derived suppressor cells, 2021-10-27

• Folate-conjugated immunoglobulin targets melanoma tumor cells for NK cell effector functions, 2016-06-08

• Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis, 2020-12-11

• The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010, 2013-09-21

• The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma, 2016-10-21

• Tissue microRNA Expression Profiling in Hepatic and Pulmonary Metastatic Melanoma, 2020-07-13

• Tumor Infiltrating Lymphocytes - The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer, 2014-11-25

• MICA-expressing monocytes enhance natural killer cell Fc receptor-mediated antitumor functions, 2017-07-19

• Endotoxemia Coupled with Heightened Inflammation Predicts Future Depressive Symptoms, 2020-10-08

• Bortezomib Pre-Treatment Prolongs Interferon-alpha Induced STAT1 Phosphorylation in Melanoma Cells, 2009-04-26

• Trajectories of stress, depressive symptoms, and immunity in cancer survivors: Diagnosis to 5 years, 2016-07-12

• Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner, 2023-04-24

• Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON, 2018-04-05

• Tissue factor-targeted immunotherapy of melanoma and triple negative breast cancer using a second generation ICON, 2015-11-04

• Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy, 2021-12-14

• Myeloid Derived Suppressor Cells in Breast Cancer, 2013-07-05

• Use of a nanoporous biodegradable miniature device to regulate cytokine release for cancer treatment, 2011-02-26

• Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival, 2012-05-05

• Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4+and CD8+T cells, 2011-05-21

• A critical role of CD200R signaling in limiting the growth and metastasis of CD200 positive melanoma, 2016-07-06

• Adjuvant Vaccine Immunotherapy of Resected, Clinically Node-negative Melanoma: Long-Term Outcome and Impact of HLA Class I Antigen Expression on Overall Survival, 2014-07-03

• Unusual recurrence of breast cancer in a BRCA-variant patient after fat grafting SKENDELAS et al., 2018-10-31

• ß-ADRENERGIC RECEPTOR MEDIATED INCREASES IN ACTIVATION AND FUNCTION OF NATURAL KILLER CELLS FOLLOWING REPEATED SOCIAL DISRUPTION, 2012-07-14

• Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy, 2008-07-27

• Interferon-alpha and bortezomib overcome Bcl-2 and Mcl-1 over-expression in melanoma cells by stimulating the extrinsic pathway of apoptosis, 2008-10-15

• Impact of age-related T cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: a prospective cohort study, 2020-09-17

• Distress Trajectories in Black and White Breast Cancer Survivors: From Diagnosis to Survivorship, 2021-05-27

• A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: Secondary analysis of a randomized controlled trial, 2009-07-21

• Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+T cells in cancer and measurement of STAT1 nitration, 2017-11-13

• Attachment anxiety is related to Epstein-Barr virus latency, 2014-06-16

• Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+T cells in cancer and measurement of STAT1 nitration, 2018-03-06

• IL-21 enhances natural killer cell response to cetuximab-coated pancreatic tumor cells, 2016-07-19

• A Phase I trial of Bortezomib and Interferon Alfa-2B in Metastatic Melanoma, 2014-07-02

• Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+T cells from patients with GI malignancy, 2011-05-21

• Relationship Satisfaction Predicts Lower Stress and Inflammation in Breast Cancer Survivors: A Longitudinal Study of Within-Person and Between-Person Effects, 2020-05-19

• CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma, 2021-10-08

• Cetuximab Therapy in Head and Neck Cancer: Immune Modulation with Interleukin-12 and Other Natural Killer Cell Activating Cytokines, 2012-07-06

• Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to Interferon-Alpha, 2008-09-15

• Increased Visceral to Subcutaneous Fat Ratio is Associated with Decreased Overall Survival in Patients with Metastatic Melanoma Receiving Anti-Angiogenic Therapy, 2015-10-22

• A progenitor cell expressing transcription factor ROR?t generates all human innate lymphoid cell subsets, 2016-05-10

• Loss of miR-1469 expression mediates melanoma cell migration and invasion, 2021-09-01

• IL-29 BINDS TO MELANOMA CELLS INDUCING JAK-STAT SIGNAL TRANSDUCTION AND APOPTOSIS, 2010-01-26

• The gut connection: Intestinal permeability as a pathway from breast cancer survivors' relationship satisfaction to inflammation across treatment, 2021-11-19

• Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship, 2023-09-04

• Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial, 2019-01-23

• Characterization of inflammatory changes in the breast cancer associated adipose tissue and comparison to the unaffected contralateral breast, 2021-09-09

• NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin are Enhanced by Cytokines, 2016-02-10

• Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival, 2023-02-24

• Myeloid derived suppressor cell inhibition of the IFN response in tumor-bearing mice, 2011-06-16

• Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor bearing hosts by ibrutinib treatment, 2016-02-15

• Monoclonal Antibody Therapy of Pancreatic Cancer with Cetuximab: Potential for Immune Modulation, 2012-04-23

• Beta-blockers May Reduce Intrusive Thoughts in Newly Diagnosed Cancer Patients, 2012-12-17

• Nitric Oxide Production by Myeloid Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function., 2018-01-23

• Impact of Breast Cancer Recurrence and Cancer-Specific Stress on Spouse Health and Immune Function, 2011-07-23

• Single-cell RNA sequencing identifies a population of human liver-type ILC1s, 2023-01-01

• Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta, 2013-11-18

• Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation, 2021-03-11

• A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies, 2009-11-03

• The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells, 2015-08-03

• Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer, 2020-05-19

• Analysis of potential biomarkers of response to IL-12 therapy, 2022-07-04

• A Pilot Study of Bevacizumab and Interferon-a2b in Ocular Melanoma, 2015-01-01

• Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes, 2019-02-26

• Signaling pathways involved in MDSC regulation, 2014-04-13

• Psychological Stress is Associated with Altered Levels of Myeloid-Derived Suppressor cells in Breast Cancer Patients, 2011-04-23

• Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer Association of Allostatic Load With Mortality Among Patients With Non-Small Cell Lung Cancer, 2022-07-07

• Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease, 2014-10-11

• IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-? Production, 2011-02-14

• Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammation, 2017-05-04

• Study of circulating myeloid derived suppressor cells (MDSC) in patients with breast cancer undergoing neo-adjuvant chemotherapy; interim results, 2013-11-07

• Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cells, 2013-03-21

• Fluorescent nanodiamonds engage innate immune effector cells: a potential vehicle for targeted anti-tumor immunotherapy, 2016-12-18